Modern approaches to the chronic glomerulonephritis classification
- Authors: Bobkova I.N.1, Lysenko L.V.1, Kamyshova E.S.1, Moiseev S.V.1
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 97, No 6 (2025): Issues of nephrology
- Pages: 484-488
- Section: Editorial
- URL: https://journal-vniispk.ru/0040-3660/article/view/313989
- DOI: https://doi.org/10.26442/00403660.2025.06.203319
- ID: 313989
Cite item
Full Text
Abstract
Chronic (CGN) glomerulonephritis (GN) is a heterogeneous group of immune-mediated kidney diseases requiring a clear classification system to optimize diagnosis and therapy. This article reviews the evolution of CGN classification, from clinical and morphological criteria to modern immunopathogenetic frameworks. The importance of categorizing CGN into five major groups (immune complex GN, antineutrophil cytoplasmic antibody (ANCA)-associated GN, anti-glomerular basement membrane disease, monoclonal immunoglobulin-associated GN, and C3-glomerulopathy) based on pathogenesis, activity, and degree of chronicity is emphasized. Advantages of immunophenotyping-based classification, integrating analysis of biopsy samples, serological markers, and genetic data, are presented. Emerging approaches enable personalized treatment, including immunosuppression, clone-oriented therapies, and targeted cytokine/complement blockade. The necessity of integrating molecular-immunological data into clinical practice to enhance diagnostic accuracy and therapeutic efficacy is highlighted. Modern CGN classification systems pave the way for targeted drug use and improved patient outcomes.
Full Text
##article.viewOnOriginalSite##About the authors
Irina N. Bobkova
Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: irbo.mma@mail.ru
ORCID iD: 0000-0002-8007-5680
д-р мед. наук, проф. каф. внутренних, профессиональных болезней и ревматологии Института клинической медицины им. Н.В. Склифосовского
Russian Federation, MoscowLidia V. Lysenko
Sechenov First Moscow State Medical University (Sechenov University)
Email: irbo.mma@mail.ru
ORCID iD: 0000-0002-1166-7308
д-р мед. наук, проф. каф. внутренних, профессиональных болезней и ревматологии Института клинической медицины им. Н.В. Склифосовского
Russian Federation, MoscowElena S. Kamyshova
Sechenov First Moscow State Medical University (Sechenov University)
Email: irbo.mma@mail.ru
ORCID iD: 0000-0002-1823-0125
канд. мед. наук, доц. каф. внутренних, профессиональных болезней и ревматологии Института клинической медицины им. Н.В. Склифосовского
Russian Federation, MoscowSergey V. Moiseev
Sechenov First Moscow State Medical University (Sechenov University)
Email: irbo.mma@mail.ru
ORCID iD: 0000-0002-7232-4640
чл.-кор. РАН, д-р мед. наук, проф., зав. каф. внутренних, профессиональных болезней и ревматологии Института клинической медицины им. Н.В. Склифосовского
Russian Federation, MoscowReferences
- Смирнов А.В., Наточин Ю.В. Нефрология: фундаментальная и клиническая. Нефрология. 2019;23(4):9-26 [Smirnov AV, Natochin YuV. Nephrology: Fundamental and clinical. Nephrology (Saint-Petersburg). 2019;23(4):9-26 (in Russian)]. doi: 10.24884/1561-6274-2019-23-4-9-26
- Sethi S, Haas M, Markowitz GS, et al. Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN. J Am Soc Nephrol. 2016;27(5):1278-87. doi: 10.1681/ASN.2015060612
- Sethi S, Fervenza FC. Standardized classification and reporting of glomerulonephritis. Nephrol Dial Transplant. 2019;34(2):193-9. doi: 10.1093/ndt/gfy220
- Сети C., Фервенца Ф.К. Стандартизированный подход к классификации и морфологическому описанию гломерулонефрита. Нефрология. 2019;23(4):27-35 [Sethi S, Fervenza FC. Standardized classification and reporting of glomerulonephritis. Nephrology (Saint-Petersburg). 2019;23(4):27-35 (in Russian)]. doi: 10.24884/1561-6274-2019-23-4-27-35
- Romagnani P, Kitching AR, Leung N, Anders HJ. The five types of glomerulonephritis classified by pathogenesis, activity and chronicity (GN-AC). Nephrol Dial Transplant. 2023;38(Suppl. 2):ii3-10. doi: 10.1093/ndt/gfad067
- Anders HJ, Kitching AR, Leung N, Romagnani P. Glomerulonephritis: Immunopathogenesis and immunotherapy. Nat Rev Immunol. 2023;23(7):453-71. doi: 10.1038/s41577-022-00816-y
- Тареев Е.М. Нефриты. М.: Медгиз, 1958 [Tareev EM. Nefrity. Moscow: Medgiz, 1958 (in Russian)].
- Основы нефрологии. Под ред. Е.М. Тареева. М.: Медицина, 1972 [Osnovy nefrologii. Pod red. EM Tareeva. Moscow: Meditsina, 1972 (in Russian)].
- Sethi S. Etiology-based diagnostic approach to proliferative glomerulonephritis. Am J Kidney Dis. 2014;63(4):561-6. doi: 10.1053/j.ajkd.2013.11.019
- Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: A reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol. 2007;2(3):529-42. doi: 10.2215/CJN.04121206
- Ravaglia F, Melica ME, Angelotti ML, et al. The pathology lesion patterns of podocytopathies: How and why? Front Cell Dev Biol. 2022;10:838272. doi: 10.3389/fcell.2022.838272
- Sethi S, Zand L, Leung N, et al. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol. 2010;5(5):770-82. doi: 10.2215/CJN.06760909
- Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: Pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol. 2011;31(4):341-8. doi: 10.1016/j.semnephrol.2011.06.005
- Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis – A new look at an old entity. N Engl J Med. 2012;366(12):1119-31. doi: 10.1056/NEJMra1108178
- Anguiano L, Kain R, Anders HJ. The glomerular crescent: triggers, evolution, resolution, and implications for therapy. Curr Opin Nephrol Hypertens. 2020;29(3):302-9. doi: 10.1097/MNH.0000000000000596
Supplementary files
